Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The Business of Pride Business of Pride Annual Celebration and Awards Ceremony! Another big biotech pledges billions for U.S. manufacturing Another big biotech pledges billions for U.S ...

Performance data quoted represents past performance, which does not guarantee future results. Current performance may be lower or higher than the figures shown. Principal value and investment ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

This cutting-edge field represents the convergence of artificial intelligence, sensor technology, and biotechnology. For investors looking beyond the quarterly hype cycle, this emerging sector ...

Shenzhen Genocury Biotech Co., Ltd. is a clinical-stage biotechnology pioneer redefining in vivo cell engineering through its proprietary Vivoexpress™ platform. This modular delivery system ...

Oversupply and demand dampened by a pullback in venture capital have plagued biotech landlords for more than a year, causing steep increases in vacancy in even the top life sciences markets.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter ...

In the basement of 55 Church St. sits one of just three NeuroExplorer PET scanners in the world. Capable of producing images with significantly better resolution and sensitivity than its 20-year-old ...

Octagon Therapeutics has thrown in the towel. The Novo Nordisk-allied autoimmune disease biotech is winding down after deprioritizing its lead program and running into unresolved biology questions.

China’s WuXi AppTec, which a US legislative commission called the “Huawei equivalent for biotechnology”, has reported a surge in US business despite increased scrutiny from Washington ...